NIH launches massive sample collection to unlock disease secrets
NCT ID NCT00071045
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 10 times
Summary
This study collects blood, bone marrow, urine, and tissue samples from up to 6,000 people with solid tumors, blood cancers, or non-cancerous blood disorders, as well as from their healthy family members who are stem cell donors. The samples are stored and used in research to better understand diseases, improve current treatments, and find new therapies. Participants give samples during routine medical care, and some adults may also donate extra white blood cells through a procedure called leukapheresis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW FAILURE CONDITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- A simple screening program could transform cancer aftercare
- Could a new pill quiet chronic pain? early trial puts it to the test
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Ear acupressure: a new weapon against chemotherapy side effects?